SPOTLIGHT -
Slideshow
Author(s):
Call for better first-episode mania care, brain activation patterns predict risk, what’s important about atypical antipsychotics- find concise summaries of these and other key developments here.
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia
Blue Light, Depression, and Bipolar Disorder
BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial
Four Myths About Lamotrigine
FDA Accepts sNDA for Uzedy Extended-Release Injectable Suspension for Bipolar I Disorder
Bipolar Disorder Research Roundup: February 18, 2025